BioSpace News Archive

Xenon Pharmaceuticals Inc., a neurology-focused biopharmaceutical company, announced that Ian Mortimer, Xenon’s President and Chief Executive Officer, along with Sherry Aulin, Xenon’s Chief Financial Officer, will participate virtually in the following investor conferences.

POINT Biopharma Global Inc today announced financial results for the third quarter ended September 30, 2021 and provided a business update.

Silverback Therapeutics, Inc. today announced the presentation of preclinical data for SBT8230 at the American Association for the Study of Liver Diseases

EV Biologics Corp, (OTC PINK:YECO), today updated shareholders with further details about its NFT dividend.

Nxt-ID, Inc., provider of personal emergency response systems, health communications devices and IoT technology, announced financial and operations results for the third quarter and nine-month period ended September 30, 2021.

Actym Therapeutics today announced that ACTM-838 has been selected as a lead clinical development candidate for the treatment of solid tumors.

PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today that the empty capsule material that makes up its CypCaps™ pancreatic cancer product does not cause skin irritation.

InterVenn Biosciences, the leader in glycoproteomics, presented results today on a predictive signature capable of identifying non-small cell lung cancer patients that will benefit most from immune checkpoint inhibitors

Capricor Therapeutics, a biotechnology company focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of a broad spectrum of diseases, announced that Dr. Linda Marbán, CEO of Capricor, has accepted an invitation to serve as the keynote speaker at the TriLink Biotechnologies Annual mRNA Day Conference, taking place virtually on November 16, 2021.

PathAI, a global provider of AI-powered technology applied to pathology announced that results from a recent exploratory biomarker analysis on digitized slides to apply AI-predicted CD8 topology assessment of patients with advanced melanoma will be presented at the annual Meeting of Society for Immunotherapy of Cancer, November 10-14 2021.